The Latest Breaking News from Prescription Drug

One of the most important features of the Inflation Reduction Act — which makes massive investments in renewable energy to curb climate change, drives down prescription drug costs and more — is what it is not: an irresponsible spending spree pushing up the federal deficit.

Bill focuses on combating climate change, lowering the cost of prescription drugs and continues subsidies for health insurance

Bill focuses on combating climate change, lowering the cost of prescription drugs and continues subsidies for health insurance

The ten most expensive drugs covered by Medicare are responsible for about a fifth of total Medicare drug spending.

It's become tiresome to see progressive politicians act like a pouting teenager who seems to think it's a sin to ever admit satisfaction with anything. Their lukewarm reaction to Senate passage of the admittedly ill-named Inflation Reduction Act won't help energize the voters Democrats need to avoid conservatives regaining Congress…

On Friday, the U.S. House of Representatives is scheduled to cap off what has been a very good week for President Joe Biden with passage of the Inflation Reduction Act, legislation that is expected to lower prescription drug costs and raise corporate taxes while helping fight rising consumer prices.

Inflation Reduction Act will reduce planet-heating emissions and lower prescription drug costs – and give Biden a crucial victory. Plus, meet Casper the ghostly octopus

WASHINGTON — Senate Democrats on Sunday passed a sweeping health care, tax and climate change bill that will allow Medicare to negotiate prescription drug costs — a significant political win as the party tries to send a message before the midterm election that it is delivering on its promises.

The legislation – which would be the largest investment yet in combating the climate crisis – now heads to the House of Representatives.

Inflation Reduction Act will reduce planet-heating emissions and lower prescription drug costs – and give Biden a crucial victory

Medicare was cleared to negotiate drug prices for the first time by the Senate’s top rules official, though the Democrats’ proposal intended to cap price increases for prescription drugs in the commercial market was blocked.